The anti-fibrotic effect of GV1001 combined with gemcitabine on treatment of pancreatic ductal adenocarcinoma.

Oncotarget · 2016 · PMC5342724 · PMID 27655706

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

a definite trendno p-value reported

However, there was a definite trend that gemcitabine and GV1001+Gemcitabine groups had tumor volume loss while control and GV1001 groups have gradual increase of their tumors.

also in 427 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.